News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endocyte, Inc. (ECYT) Announces Second Quarter 2013 Earnings Conference Call


7/19/2013 9:56:29 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., July 18, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that the company will host a conference call on Thursday, Aug. 1, at 4:30 p.m. EDT to discuss its second quarter 2013 financial results and provide an operational update.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES